Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-11

Clinical Trial Update: Evaluating a Combination of Immune-based Therapies to Achieve a Remission of HIV Infection [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/phase 2 clinical trial evaluating a combination of immune-based therapies for HIV infection has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Judit Pich | Conditions: HIV Infections | Phase 1, Phase 2 | Status: WITHDRAWN